[1]何永成,马国杰.中医分期治疗溃疡性结肠炎43例[J].西部中医药,2018,31(08):81-83.
 HE Yongcheng,MA Guojie.TCM Phased Therapy in Treating 43 Cases of Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2018,31(08):81-83.
点击复制

中医分期治疗溃疡性结肠炎43例()
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
31
期数:
2018年08期
页码:
81-83
栏目:
报道·临证经验
出版日期:
2018-08-15

文章信息/Info

Title:
TCM Phased Therapy in Treating 43 Cases of Ulcerative Colitis
文章编号:
004-6852(2018)08-0081-03
作者:
何永成马国杰
临夏回族自治州中医院内科,甘肃 临夏 731100
Author(s):
HE Yongcheng MA Guojie
Department of Internal Medicine,Linxia Hui Autonomous Prefecture Hospital of Chinese Medicine, Linxia 731100, China
关键词:
结肠炎溃疡性辨证论治肿瘤坏死因子α白介素6白介素8
Keywords:
Objective: To observe clinical effects of TCM phased therapy in the treatment for ulcerative colitis (UC). Methods: All 83 UC patients were randomized into the observation group (43 cases) and the control group (40 cases) the observation group used TCM p
分类号:
R516.1
文献标志码:
B
摘要:
目的:观察中医分期治疗溃疡性结肠炎(UC)的临床疗效。方法:将83例UC患者随机分为观察组43例、对照组40例,观察组采用中医分期辨证论治,对照组采用美沙拉嗪肠溶片治疗,观察2组治疗前后血清肿瘤坏死因子α(TNF-α)、白介素6(IL-6)、白介素8(IL-8)变化情况及药物安全性、临床疗效和复发率。结果:血清TNF-α、IL-6、IL-8水平治疗前后2组组内比较,差异有统计学意义(P<0.05);治疗后2组组间比较,差异无统计学意义(P>0.05)。缓解率2组比较,差异无统计学意义(P>0.05);复发率2组比较,差异有统计学意义(P<0.05)。安全性评价观察组优于对照组(P<0.05)。结论:中医分期治疗UC患者,临床疗效与西医治疗相当,可有效改善血清中炎症因子水平,明显提高药物安全性,降低复发率。
Abstract:
Objective: To observe clinical effects of TCM phased therapy in the treatment for ulcerative colitis (UC). Methods: All 83 UC patients were randomized into the observation group (43 cases) and the control group (40 cases), the observation group used TCM phased therapy based on syndrome differentiation and treatment, the control group adopted mesalazine enteric-coated tablets, the recurrence rate, curative effects, drug safety, the changes of IL-8, IL-6 and TNF-α of both groups were observed before and after treating. Results: The difference had statistical meaning in the comparisons of the levels of IL-8, IL-6 and TNF-α within the groups between before and after treating (P<0.05); the difference had no statistical meaning in the comparisons between both groups after treating (P>0.05). The difference showed no statistical meaning in the comparison of the remission rate between both groups (P>0.05); the difference presented statistical meaning in the comparisons of the recurrence rate between both groups (P<0.05). The observation group was superior to the control group in assessing the safety (P<0.05). Conclusion: TCM phased therapy in the treatment for UC could effectively improve the levels of inflammatory factors in the serum, obviously raise drug safety and decrease the recurrence rate, and its effects are equivalent to these of Western medicine.

相似文献/References:

[1]黄文静.猴耳环消炎颗粒治疗婴幼儿过敏性结肠炎40例[J].西部中医药,2019,32(06):80.
 HUANG Wenjing.Treating 40 Cases of Infantile Allergic Colitis with HouErHuan XiaoYan Granules[J].Western Journal of Traditional Chinese Medicine,2019,32(08):80.
[2]武颜荣,阚存玲.固本益肠片联合美沙拉嗪片治疗中重度溃疡性结肠炎19例*[J].西部中医药,2013,26(01):79.
 WU Yanrong,KAN Cunling.Clinical Observation on GuBen Y iChang Tablets and Mesalazine Tablets in Treating Moderate and Severe Ulcerative Colitis:A Report of 19 Cases[J].Western Journal of Traditional Chinese Medicine,2013,26(08):79.
[3]冉玉.消溃愈疡汤联合艾迪莎治疗溃疡性结肠炎50例[J].西部中医药,2013,26(03):101.
 RAN Yu.XiaoKui YuYangTang and Etiasa in Treating 50 Cases of Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2013,26(08):101.
[4]景姗,王新月,杨雪,等.溃疡性结肠炎大鼠肺、肠组织中TGF-β1、SP-A表达的改变及中药的干预作用*[J].西部中医药,2014,27(03):10.
 JING Shan,WANG Xinyue,YANG Xue,et al.The Expressions of TGF-β1 and SP-A in the Lung and the Intestines of Rats with Ulcerative Colitis and TCM Intervention on the Changes[J].Western Journal of Traditional Chinese Medicine,2014,27(08):10.
[5]张艳.初发与复发溃疡性结肠炎院外治疗依从性的调查与分析[J].西部中医药,2017,30(02):58.
 ZHANG Yan.Investigation and Analysis of Extramural Hospital Treatment Compliance of Incipient and Relapse Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2017,30(08):58.
[6]丁永福.健脾清肠汤治疗脾虚湿热型溃疡性结肠炎40例[J].西部中医药,2018,31(02):88.
 DING Yongfu.JianPi QingChang Decoction in Treating 40 Cases of Ulcerative Colitis of Spleen-deficiency Damp-heat Pattern[J].Western Journal of Traditional Chinese Medicine,2018,31(08):88.
[7]杨薇薇.SASP加中药保留灌肠治疗溃疡性结肠炎64例[J].西部中医药,2019,32(01):102.
 YANG Weiwei.Treating 64 Cases of Ulcerative Colitis by SASP and Herbal Retention Enema[J].Western Journal of Traditional Chinese Medicine,2019,32(08):102.
[8]陈步强,常忠生,指导:陆金根.陆金根教授治疗轻中度溃疡性结肠炎学术思想探析[J].西部中医药,2020,33(02):47.[doi:10.12174/j.issn.1004-6852.2020.02.13]
 CHEN Buqiang,CHANG ZhongshengDirector: LU Jingen.Professor Lu Jingen′s Academic Thinking of Treating Mild - to - moderate Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2020,33(08):47.[doi:10.12174/j.issn.1004-6852.2020.02.13]
[9]沈照峰,朱磊,刘亚军,等.基于德尔菲法的溃疡性结肠炎患者相关危险因素调查分析[J].西部中医药,2020,33(04):82.[doi:10.12174/j.issn.1004-6852.2020.04.25]
 SHEN Zhaofeng,ZHU Lei,LIU Yajun,et al.An Investigation into the Related Risk Factors of UC Patients Based on Delphi Method[J].Western Journal of Traditional Chinese Medicine,2020,33(08):82.[doi:10.12174/j.issn.1004-6852.2020.04.25]

备注/Memo

备注/Memo:
收稿日期:2018-02-15 作者简介:何永成(1964—),男,副主任医师。研究方向:内科疾病的中医诊治。
更新日期/Last Update: 2018-08-15